These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

186 related articles for article (PubMed ID: 23554851)

  • 1. Evaluation of anti-hyperalgesic and analgesic effects of two benzodiazepines in human experimental pain: a randomized placebo-controlled study.
    Vuilleumier PH; Besson M; Desmeules J; Arendt-Nielsen L; Curatolo M
    PLoS One; 2013; 8(3):e43896. PubMed ID: 23554851
    [TBL] [Abstract][Full Text] [Related]  

  • 2. GABAergic modulation in central sensitization in humans: a randomized placebo-controlled pharmacokinetic-pharmacodynamic study comparing clobazam with clonazepam in healthy volunteers.
    Besson M; Matthey A; Daali Y; Poncet A; Vuillemier P; Curatolo M; Zeilhofer HU; Desmeules J
    Pain; 2015 Mar; 156(3):397-404. PubMed ID: 25687539
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effect of transdermal opioids in experimentally induced superficial, deep and hyperalgesic pain.
    Andresen T; Staahl C; Oksche A; Mansikka H; Arendt-Nielsen L; Drewes AM
    Br J Pharmacol; 2011 Oct; 164(3):934-45. PubMed ID: 21182491
    [TBL] [Abstract][Full Text] [Related]  

  • 4. GABAergic modulation of secondary hyperalgesia: A randomized controlled 4-way crossover trial with the α2-subunit preferring GABA positive allosteric modulator, N-desmethyl-clobazam in healthy volunteers.
    Matthey A; Daali Y; Curtin F; Poncet A; Desmeules J; Besson M
    Eur J Pain; 2020 Jul; 24(6):1094-1106. PubMed ID: 32171038
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Antihyperalgesic and analgesic properties of the N-methyl-D-aspartate (NMDA) receptor antagonist neramexane in a human surrogate model of neurogenic hyperalgesia.
    Klein T; Magerl W; Hanschmann A; Althaus M; Treede RD
    Eur J Pain; 2008 Jan; 12(1):17-29. PubMed ID: 17449306
    [TBL] [Abstract][Full Text] [Related]  

  • 6. HZ166, a novel GABAA receptor subtype-selective benzodiazepine site ligand, is antihyperalgesic in mouse models of inflammatory and neuropathic pain.
    Di Lio A; Benke D; Besson M; Desmeules J; Daali Y; Wang ZJ; Edwankar R; Cook JM; Zeilhofer HU
    Neuropharmacology; 2011 Mar; 60(4):626-32. PubMed ID: 21145329
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effect of morphine and pregabalin compared with diphenhydramine hydrochloride and placebo on hyperalgesia and allodynia induced by intradermal capsaicin in healthy male subjects.
    Wang H; Bolognese J; Calder N; Baxendale J; Kehler A; Cummings C; Connell J; Herman G
    J Pain; 2008 Dec; 9(12):1088-95. PubMed ID: 19038771
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Lack of effect of two oral sodium channel antagonists, lamotrigine and 4030W92, on intradermal capsaicin-induced hyperalgesia model.
    Wallace MS; Quessy S; Schulteis G
    Pharmacol Biochem Behav; 2004 Jun; 78(2):349-55. PubMed ID: 15219777
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effect of chronic oral gabapentin on capsaicin-induced pain and hyperalgesia: a double-blind, placebo-controlled, crossover study.
    Wallace MS; Schulteis G
    Clin J Pain; 2008; 24(6):544-9. PubMed ID: 18574364
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Postdelivery of alfentanil and ketamine has no effect on intradermal capsaicin-induced pain and hyperalgesia.
    Wallace MS; Braun J; Schulteis G
    Clin J Pain; 2002; 18(6):373-9. PubMed ID: 12441831
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Lack of analgesia by oral standardized cannabis extract on acute inflammatory pain and hyperalgesia in volunteers.
    Kraft B; Frickey NA; Kaufmann RM; Reif M; Frey R; Gustorff B; Kress HG
    Anesthesiology; 2008 Jul; 109(1):101-10. PubMed ID: 18580179
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Concentration-effect relationships for intravenous alfentanil and ketamine infusions in human volunteers: effects on acute thresholds and capsaicin-evoked hyperpathia.
    Wallace MS; Ridgeway B; Leung A; Schulteis G; Yaksh TL
    J Clin Pharmacol; 2002 Jan; 42(1):70-80. PubMed ID: 11808827
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Evaluation of the analgesic efficacy and psychoactive effects of AZD1940, a novel peripherally acting cannabinoid agonist, in human capsaicin-induced pain and hyperalgesia.
    Kalliomäki J; Annas P; Huizar K; Clarke C; Zettergren A; Karlsten R; Segerdahl M
    Clin Exp Pharmacol Physiol; 2013 Mar; 40(3):212-8. PubMed ID: 23324098
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effect of oral mexiletine on capsaicin-induced allodynia and hyperalgesia: a double-blind, placebo-controlled, crossover study.
    Ando K; Wallace MS; Braun J; Schulteis G
    Reg Anesth Pain Med; 2000; 25(5):468-74. PubMed ID: 11009231
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Placebo-controlled comparison of a morphine/dextromethorphan combination with morphine on experimental pain and hyperalgesia in healthy volunteers.
    Frymoyer AR; Rowbotham MC; Petersen KL
    J Pain; 2007 Jan; 8(1):19-25. PubMed ID: 17113353
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Differential effects of peripheral ketamine and lidocaine on skin flux and hyperalgesia induced by intradermal capsaicin in humans.
    Gottrup H; Bach FW; Jensen TS
    Clin Physiol Funct Imaging; 2004 Mar; 24(2):103-8. PubMed ID: 15056183
    [TBL] [Abstract][Full Text] [Related]  

  • 17. GABA(A) receptor physiology and its relationship to the mechanism of action of the 1,5-benzodiazepine clobazam.
    Sankar R
    CNS Drugs; 2012 Mar; 26(3):229-44. PubMed ID: 22145708
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Concentration-effect relationship of intravenous alfentanil and ketamine on peripheral neurosensory thresholds, allodynia and hyperalgesia of neuropathic pain.
    Leung A; Wallace MS; Ridgeway B; Yaksh T
    Pain; 2001 Mar; 91(1-2):177-87. PubMed ID: 11240090
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Antihyperalgesic effect of the GABA(A) ligand clobazam in a neuropathic pain model in mice: a pharmacokinetic-pharmacodynamic study.
    Besson M; Daali Y; Di Lio A; Dayer P; Zeilhofer HU; Desmeules J
    Basic Clin Pharmacol Toxicol; 2013 Mar; 112(3):192-7. PubMed ID: 23006671
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The clobazam metabolite N-desmethyl clobazam is an α2 preferring benzodiazepine with an improved therapeutic window for antihyperalgesia.
    Ralvenius WT; Acuña MA; Benke D; Matthey A; Daali Y; Rudolph U; Desmeules J; Zeilhofer HU; Besson M
    Neuropharmacology; 2016 Oct; 109():366-375. PubMed ID: 27392635
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.